BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 9143697)

  • 1. CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling.
    Tedder TF; Tuscano J; Sato S; Kehrl JH
    Annu Rev Immunol; 1997; 15():481-504. PubMed ID: 9143697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ig domains 1 and 2 of murine CD22 constitute the ligand-binding domain and bind multiple sialylated ligands expressed on B and T cells.
    Law CL; Aruffo A; Chandran KA; Doty RT; Clark EA
    J Immunol; 1995 Oct; 155(7):3368-76. PubMed ID: 7561031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD22 associates with the human surface IgM-B-cell antigen receptor complex.
    Leprince C; Draves KE; Geahlen RL; Ledbetter JA; Clark EA
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3236-40. PubMed ID: 8475064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD22 negatively and positively regulates signal transduction through the B lymphocyte antigen receptor.
    Sato S; Tuscano JM; Inaoki M; Tedder TF
    Semin Immunol; 1998 Aug; 10(4):287-97. PubMed ID: 9695185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of CD22 with the B cell antigen receptor.
    Peaker CJ; Neuberger MS
    Eur J Immunol; 1993 Jun; 23(6):1358-63. PubMed ID: 7684686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD22 forms a quaternary complex with SHIP, Grb2, and Shc. A pathway for regulation of B lymphocyte antigen receptor-induced calcium flux.
    Poe JC; Fujimoto M; Jansen PJ; Miller AS; Tedder TF
    J Biol Chem; 2000 Jun; 275(23):17420-7. PubMed ID: 10748054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of the putative sialic acid-binding site on the immunoglobulin superfamily cell-surface molecule CD22.
    van der Merwe PA; Crocker PR; Vinson M; Barclay AN; Schauer R; Kelm S
    J Biol Chem; 1996 Apr; 271(16):9273-80. PubMed ID: 8621588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the ligand-binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid-dependent ligand.
    Engel P; Wagner N; Miller AS; Tedder TF
    J Exp Med; 1995 Apr; 181(4):1581-6. PubMed ID: 7535343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single N-linked glycosylation site is implicated in the regulation of ligand recognition by the I-type lectins CD22 and CD33.
    Sgroi D; Nocks A; Stamenkovic I
    J Biol Chem; 1996 Aug; 271(31):18803-9. PubMed ID: 8702538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils, and monocytes.
    Engel P; Nojima Y; Rothstein D; Zhou LJ; Wilson GL; Kehrl JH; Tedder TF
    J Immunol; 1993 Jun; 150(11):4719-32. PubMed ID: 7684411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice.
    Sato S; Miller AS; Inaoki M; Bock CB; Jansen PJ; Tang ML; Tedder TF
    Immunity; 1996 Dec; 5(6):551-62. PubMed ID: 8986715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily.
    Kelm S; Pelz A; Schauer R; Filbin MT; Tang S; de Bellard ME; Schnaar RL; Mahoney JA; Hartnell A; Bradfield P
    Curr Biol; 1994 Nov; 4(11):965-72. PubMed ID: 7533044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation.
    Law CL; Sidorenko SP; Chandran KA; Zhao Z; Shen SH; Fischer EH; Clark EA
    J Exp Med; 1996 Feb; 183(2):547-60. PubMed ID: 8627166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction.
    Poe JC; Hasegawa M; Tedder TF
    Int Rev Immunol; 2001; 20(6):739-62. PubMed ID: 11913948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
    Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
    Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of CD22 and other inhibitory co-receptors in B-cell activation.
    Nitschke L
    Curr Opin Immunol; 2005 Jun; 17(3):290-7. PubMed ID: 15886119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of MHC class II signal transduction by the B cell coreceptors CD19 and CD22.
    Bobbitt KR; Justement LB
    J Immunol; 2000 Nov; 165(10):5588-96. PubMed ID: 11067914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the expression and gene promoter of CD22 in murine B cells.
    Andersson KB; Draves KE; Magaletti DM; Fujioka S; Holmes KL; Law CL; Clark EA
    Eur J Immunol; 1996 Dec; 26(12):3170-8. PubMed ID: 8977319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD22.
    Engel P
    J Biol Regul Homeost Agents; 2000; 14(4):295-8. PubMed ID: 11215824
    [No Abstract]   [Full Text] [Related]  

  • 20. CD22 regulates thymus-independent responses and the lifespan of B cells.
    Otipoby KL; Andersson KB; Draves KE; Klaus SJ; Farr AG; Kerner JD; Perlmutter RM; Law CL; Clark EA
    Nature; 1996 Dec 19-26; 384(6610):634-7. PubMed ID: 8967951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.